Skip to content

Pregnancy Outcomes in Congenital Myasthenie Syndrome

Retrospective Study :Describe the Changes of the Disease in Many Cases Likely to Aggravate.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01474980
Acronym
POCoMS
Enrollment
25
Registered
2011-11-18
Start date
2010-01-31
Completion date
2011-10-31
Last updated
2011-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Myasthenic Syndrome

Keywords

Congenital Myasthenic Syndrome, Pregnancy, Outcome

Brief summary

This is a retrospective study that follows the clinical evolution, the pregnancy and the post-partum perioad of female patients with Congenital Myasthenic Syndrome.

Detailed description

The aim of this study is to better understand the action of hormonal factors that are presumably incriminated for the fluctuation of the disease. The investigators would also like to better adress the issues of women with Congenital Myasthenic Syndrome, who desire a pregnancy : the possibility of decompensation, the problems that can arise during the course of the childbearing, the risk of foetal malformations.

Interventions

None listed

Sponsors

Assistance Publique - Hôpitaux de Paris
CollaboratorOTHER
Institut de Myologie, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult women * Congenital myastenic syndrome genetically confirmed or with clinical compatible and electrophysiological evidence * Written consent

Exclusion criteria

* Neurological or general pathology occurs significantly with the initiation and conduct of a pregnancy.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026